Get Articles Daily from StraightStocks - Enter Email Address


  • National Debt Clock


Medefile, Inc. (OTC: MDFI) Backed by Experienced Board of Directors

Source: http://Blog.QualityStocks.net/?p=11579
Posted on Tuesday, August 5th, 2008 | In Market Commentary, OTCBB Markets, Small & Micro Cap, Stocks to Watch
Contributed by: QualityStocks (http://QualityStocks.net) -

Medefile International, Inc. (OTC: MDFI), through their subsidiary, Medefile, Inc., is focused on developing a system for the healthcare field that gathers, digitizes, stores, and distributes information in an organized and timely manner. The company has created a system for individuals to have a record of all their medical visits. The MedeFile system, which is the company’s primary product, is a secure system for gathering and maintaining medical records. The MedeFile system is designed to gather all of their members’ medical records and create a single, comprehensive medical record that is accessible at any time.

Milton Hauser is the President/CEO and chairman of the board for Medefile. With over thirty years of advertising and marketing experience, Mr. Hauser has been at the center of executing many high-profile national campaigns and programs for numerous global companies such as Panasonic, Sanyo, Avon, and Lederle International, as well as multiple Fortune 500 companies. For sixteen years, he earned the distinction as an award winning writer/producer of both television commercials and industrial productions at his own production company. During that time he also served as the company’s president. His experience within the medical field is vast as he worked closely with a number of leading pharmaceutical companies developing and implementing strategic advertising, branding, and marketing strategies for a wide range of medical and pharmaceutical products.

Serving as the Chief Information Officer and Director of Medefile is Eric Rosenfeld. Working as a principal consultant for Oracle Corporation, Mr. Rosenfeld soon became the leader of Oracle’s New York Metro consulting practice. Additionally, he served as a contributor to Oracle’s development tools and consulting methodologies, which have been included in their designer and CDM products. He has experience in the medical field as he consulted directly with the Food and Drug Administration (FDA), the United States Department of Health and Human Services (HHS), and the National Institutes of Health (NIH) on issues relating to healthcare management, healthcare reform, drug approval processes, and data management and analysis. One of his biggest achievements was that of forming and owning his own consulting company where he served as the president and CEO, and within two years of company operations, generated over $10 million in revenues.

Medefile’s Chairman of the Audit Committee is Mr. Peter Leveton. Combining more than twenty years experience as CEO/CFO and seventeen years experience as a member of the board of directors of public and privately owned companies in the healthcare and medical devices field, chemical manufacturing and natural resources, commercial and residential real estate development, and over four years as partner in a healthcare-focused boutique investment banking firm. Mr. Leveton is well-established within many industries. He held the position of CEO at a major subsidiary of Rose Health Care Systems, a leading Denver, Colorado acute care hospital holding company. He held the same position with Surgical Acuity, Inc., a leading manufacturer of dental and medical loupes to help dentists and physicians see and perform better.

Let us hear your thoughts below:

Last 5 posts by QualityStocks





About QualityStocks (http://QualityStocks.net)

Our name, QualityStocks, emphasizes our commitment to connect subscribers with companies that have huge potential to succeed in the short and long-term future. We believe strong management and vision for the future are crucial for any company to be successful. Timing is everything and we help investors succeed by providing an objective, broad-based view of the SmallCap markets on a daily basis.

Please see disclaimer on QualityStocks website: http://disclaimer.qualitystocks.net

No Responses to “Medefile, Inc. (OTC: MDFI) Backed by Experienced Board of Directors”

  1. Ed Baker Says:
    March 18th, 2009 at 9:09 am

    MedeFile International and its products are a sham. The service is useless to physicians and they fradulently claim to be able to assist in urgent or acute care. This is good example of the snake oil passing as qualified medical tools and technologies. Look closer at their web site and company info available throughout the Internet. They have no substance or medical components whatsoever. They have no medical personnel on staff.

    Furthermore, a few of my patients report that their records supposedly collected on their behalf by the MedeFile service, were incomplete, overly costly (in one case exceeding $500) and horribly presentede and contructed. For patients facing chronic illness, this service may provide dangerously false hopes. I know of no serious physician that consider this product either usable or helpful in a treatment or diagnostic capacity.

    BEWARE! Medefile offers nothing! Check with your doctor first!

Leave a Reply

Name

Email (kept private)

Website









No recommendations, either expressed or implied, are being made to buy, sell, hold or short any of the mentioned stocks. No legal, tax or accounting advice is expressed or implied. Always contact your attorney, CPA, or tax advisor before acting on any legal or tax issues. StraightStocks.com is not responsible for the content, products, or services of any of the advertisers on this site. StraightStocks.com receives compensation from advertisers on this blog. Services and products referred to herein are trademarks, registered trademarks, servicemarks, and/or registered servicemarks of their respective trademark or servicemark owners.